Because CDK5 and GSK3β are directly involved in tau phosphorylation, the significant decrease in inactive GSK3β suggests that GSK3β activation may be involved in the MEM-induced increase in P-tau levels during the 28-day CRS. The gene discussed is MAPT; the disease is congenital rubella syndrome.